Flerie (DB:1NP1) - Stock Price, News & Analysis

1NP1 Stock Overview

A venture capital firm specializing in early-stage investments.

1NP1 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Has not reported any financial data

Highly volatile share price over the past 3 months

Flerie AB (publ) Competitors

Alimera Sciences

DB:ASZ1

€257.0m

PharmaSGP Holding

XTRA:PSG

€254.2m

MPH Health Care

DB:93M1

€104.5m

Pierrel

DB:2FJ0

€92.8m

Price History & Performance

Summary of all time highs, changes and price drops for Flerie
Historical stock prices
Current Share Price	SEK 3.65
52 Week High	SEK 4.17
52 Week Low	SEK 2.08
Beta	0
11 Month Change	-1.48%
3 Month Change	13.35%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-2.93%

Recent updates

Shareholder Returns

	1NP1	DE Pharmaceuticals	DE Market
7D	-2.5%	-4.0%	1.0%
1Y	n/a	-15.0%	11.2%

Return vs Industry: Insufficient data to determine how 1NP1 performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 1NP1 performed against the German Market.

Price Volatility

Is 1NP1's price volatile compared to industry and market?
1NP1 volatility
1NP1 Average Weekly Movement	26.3%
Pharmaceuticals Industry Average Movement	5.1%
Market Average Movement	5.0%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 1NP1's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 1NP1's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	n/a	Ted Fjallman	www.flerie.com

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel.

Flerie AB (publ) Fundamentals Summary

How do Flerie's earnings and revenue compare to its market cap?
1NP1 fundamental statistics
Market cap	€293.57m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 1NP1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1NP1 income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 1NP1 perform over the long term?

See historical performance and comparison

Flerie DB:1NP1 Stock Report